Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT01563302
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 years or older
* Tumors that are relapsed or refractory to at least 1 prior anti-cancer systemic therapy and for which no standard therapy exists
* Expansion cohort only: Advanced lymphoma confirmed by histopathology
* Measurable or evaluable disease according to RECIST for solid tumors or according to IWRC for NHL tumors
* ECOG Performance Status less than or equal to 2
* Life expectancy greater than 12 weeks in the opinion of the Investigator
Exclusion Criteria:
* Any active or uncontrolled infection
* NYHA Grade II or greater congestive heart failure
* History of myocardial infarction within 6 months prior to screening
* Prior radiation therapy, chemotherapy, hormonal therapy, or immunotherapy within 4 weeks prior to screening or 5 half-lives of the therapy, whichever is shorter
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01563302
Study Brief:
Protocol Section:
NCT01563302